Diagnostic Utility of Serum and Urinary Metabolite Analysis in Patients with Interstitial Cystitis/Painful Bladder Syndrome



      To identify the potential biomarkers of interstitial cystitis/painful bladder syndrome (IC), a chronic syndrome of bladder-centric pain with unknown etiology that has an adverse impact on quality of life, we analyzed the urine and serum metabolomes of a cohort of IC patients and non-disease controls (NC).


      Home collection of serum and urine samples was obtained from 19 IC and 20 NC females in the Veterans Affairs (VA) Health Care System. IC was diagnosed independently by thorough review of medical records using established criteria. Biostatistics and bioinformatics analyses, including univariate analysis, unsupervised clustering, random forest analysis, and metabolite set enrichment analysis (MSEA), were then utilized to identify potential IC biomarkers.


      Metabolomics profiling revealed distinct expression patterns between NC and IC. Random forest analysis of urine samples suggested discriminators specific to IC; these include phenylalanine, purine, 5-oxoproline, and 5-hydroxyindoleacetic acid. When these urinary metabolomics-based analytes were combined into a single model, the AUC was 0.92, suggesting strong potential clinical value as a diagnostic signature. Serum-based metabolomics did not provide potential IC discriminators.


      Analysis of serum and urine revealed that women with IC have distinct metabolomes, highlighting key metabolic pathways that may provide insight into the pathophysiology of IC. The findings from this pilot study suggest that integrated analyses of urinary metabolites, purine, phenylalanine, 5-oxoproline, and 5-HIAA, can lead to promising IC biomarkers for pathophysiology of IC. Validation of these results using a larger dataset is currently underway.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Abrams P
        • Cardozo L
        • Fall M
        • et al.
        The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.
        Am J Obstet Gynecol. 2002; 187: 116-126
        • Hanno P
        • Levin RM
        • Monson FC
        • et al.
        Diagnosis of interstitial cystitis.
        J Urol. 1990; 143: 278-281
        • Hanno P
        • Keay S
        • Moldwin R
        • Van Ophoven A
        International Consultation on IC - Rome, September 2004/Forging an International Consensus: progress in painful bladder syndrome/interstitial cystitis. Report and abstracts.
        Int Urogynecol J Pelvic Floor Dysfunct. 2005; : S2-S34
        • Ness TJ
        • Powell-Boone T
        • Cannon R
        • Lloyd LK
        • Fillingim RB.
        Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis.
        J Urol. 2005; 173: 1983-1987
        • Warren JW
        • Keay SK.
        Interstitial cystitis.
        Curr Opin Urol. 2002; 12: 69-74
        • Nordling J
        • Anjum FH
        • Bade JJ
        • et al.
        Primary evaluation of patients suspected of having interstitial cystitis (IC).
        Eur Uro. 2004; 45: 662-669
        • Hanno PM
        • Burks DA
        • Clemens JQ
        • et al.
        AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.
        J Urol. 2011; 185: 2162-2170
        • Moutzouris DA
        • Falagas ME.
        Interstitial cystitis: an unsolved enigma.
        Clin J Am Soc Nephrol. 2009; 4: 1844-1857
        • Choe JH
        • Son H
        • Song YS
        • Kim JC
        • Lee JZ
        • Lee KS.
        Prevalence of painful bladder syndrome/interstitial cystitis-like symptoms in women: a population-based study in Korea.
        World J Urol. 2011; 29: 103-108
        • Temml C
        • Wehrberger C
        • Riedl C
        • Ponholzer A
        • Marszalek M
        • Madersbacher S.
        Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project.
        Eur Uro. 2007; 51 (discussion 809): 803-808
        • Patnaik SS
        • Lagana AS
        • Vitale SG
        • et al.
        Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome.
        Arch Gynecol Obstet. 2017; 295: 1341-1359
        • Berry SH
        • Elliott MN
        • Suttorp M
        • et al.
        Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.
        J Urol. 2011; 186: 540-544
        • Skove SL
        • Howard LE
        • Senechal J
        • et al.
        The misdiagnosis of interstitial cystitis/bladder pain syndrome in a VA population.
        Neurourol Urodyn. 2019; 38: 1966-1972
        • Mazeaud C
        • Rigaud J
        • Levesque A
        • et al.
        Stratification of patients with interstitial cystitis/bladder pain syndrome according to the anatomical bladder capacity.
        Urolo. 2019; 123: 87-92
        • Malde S
        • Palmisani S
        • Al-Kaisy A
        • Sahai A.
        Guideline of guidelines: bladder pain syndrome.
        BJU Int. 2018; 122: 729-743
        • Andersson KE.
        Purinergic signalling in the urinary bladder.
        Auton Neurosci. 2015; 191: 78-81
        • Birder LA.
        Pathophysiology of interstitial cystitis.
        Int J Urol. 2019; : 12-15
        • You S
        • Yang W
        • Anger JT
        • Freeman MR
        • Kim J.
        Omics' approaches to understanding interstitial cystitis/painful bladder syndrome/bladder pain syndrome.
        Int Neurourol J. 2012; 16: 159-168
        • Tudrej KB
        • Piecha T
        • Kozlowska-Wojciechowska M.
        Role of NLRP3 inflammasome in the development of bladder pain syndrome interstitial cystitis.
        Ther Adv Urol. 2019; 11 (1756287218818030)
        • Grundy L
        • Caldwell A
        • Brierley SM.
        Mechanisms underlying overactive bladder and interstitial cystitis/painful bladder syndrome.
        Front Neurosci. 2018; 12: 931
        • Rosen JM
        • Klumpp DJ.
        Mechanisms of pain from urinary tract infection.
        Int J Urol. 2014; : 26-32
        • Yoshimura N
        • Oguchi T
        • Yokoyama H
        • et al.
        Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.
        Int J Urol. 2014; : 18-25
        • Olivier M
        • Asmis R
        • Hawkins GA
        • Howard TD
        • Cox LA.
        The need for multi-omics biomarker signatures in precision medicine.
        Int J Mol Sci. 2019; : 20
        • Baskin AS
        • Linderman JD
        • Brychta RJ
        • et al.
        Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a beta3-adrenergic receptor agonist.
        Diabetes. 2018; 67: 2113-2125
        • Drolet J
        • Tolstikov V
        • Williams BA
        • et al.
        Integrated metabolomics assessment of human dried blood spots and urine strips.
        Metabolites. 2017; 7
        • Gacias M
        • Gaspari S
        • Santos PM
        • et al.
        Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior.
        Elife. 2016; 5
        • Tolstikov V
        • Nikolayev A
        • Dong S
        • Zhao G
        • Kuo MS.
        Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.
        PLoS One. 2014; 9e114019
        • Hsieh TF
        • Yu KJ
        • Lin SY.
        Possible application of Raman microspectroscopy to verify the interstitial cystitis diagnosis after potassium sensitivity test: phenylalanine or tryptophan as a biomarker.
        Dis Markers. 2007; 23: 147-152
        • Taidi Z MK
        • Bates L
        • Sana-Ur-Rehman H
        • Liu L
        Purinergic P2 × 7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
        Bladder. 2019; 6: e38
        • Sun Y
        • Chai TC.
        Up-regulation of P2 × 3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis.
        J Urol. 2004; 171: 448-452